Cases & Deals

Board of Trustees of Univ. of Illinois files patent infringement action against Aurobindo involving generic versions of Prezista®

Clients Board of Trustees of the University of Illinois

Jones Day is representing the Board of Trustees of the University of Illinois in a patent infringement action against Aurobindo Pharma USA, Inc. relating to the defendant’s submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of Prezista® (darunavir), a market-leading protease inhibitor. The Firm is working closely with the United States, which co-owns the patent-in-suit, and with our licensee Janssen Products, L.P., which markets Prezista® (darunavir).

US Department of Health and Human Services et al. v. Aurobindo Pharma USA Inc., No. 3-17-cv-06911 (D.N.J.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.